Andrew Kruegel Net Worth (Estimated)

Who is Andrew Kruegel?

Andrew Kruegel is a co-founder of Gilgamesh Pharmaceuticals, which focuses on developing novel therapeutics inspired by the power of plant biology.

Highlights:

• Stanford University
• Harvard University
• Y Combinator S20

About Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Model inputs

• Stage: series-a
• Valuation tier: raise-10x
• Funding input: reported raise $60.0M
• Valuation note: Leftover $60M homepage scrape matches the published spinout Series A. Lock A, not the prior $39M B and not AbbVie’s up-to-$1.2B asset deal.
• Research as-of: 2026-09-14
• Funding source: https://www.prnewswire.com/news-releases/gilgamesh-pharma-closes-oversubscribed-60-million-series-a-to-develop-next-generation-neuropsychiatric-therapies-302723671.html

FAQ: Andrew Kruegel net worth and Gilgamesh Pharmaceuticals valuation

What is Andrew Kruegel's net worth?

Andrew Kruegel's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.

Andrew Kruegel net worth

Andrew Kruegel's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. This Andrew Kruegel net worth figure is estimated paper wealth, not a verified statement of assets.

How much is Andrew Kruegel worth?

Andrew Kruegel's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. How much Andrew Kruegel is worth here means estimated paper wealth from public company and role data — not financial advice.

How rich is Andrew Kruegel?

Andrew Kruegel's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. “How rich is Andrew Kruegel” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.

Andrew Kruegel fortune

Andrew Kruegel's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. This Andrew Kruegel fortune figure is estimated paper wealth only, not a verified statement of assets.

Andrew Kruegel equity value

Andrew Kruegel's estimated net worth / paper wealth is $56.0M (range $39.2M–$84.0M) as of 2026. Andrew Kruegel equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.

What is Gilgamesh Pharmaceuticals valuation?

Gilgamesh Pharmaceuticals's estimated valuation on Entrepreneurial Check is $600.0M. Independent model output, not a verified appraisal or official mark.

What is Gilgamesh Pharmaceuticals post-money valuation?

Gilgamesh Pharmaceuticals's estimated valuation on Entrepreneurial Check is $600.0M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.

What is Gilgamesh Pharmaceuticals funding?

Gilgamesh Pharmaceuticals funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Gilgamesh Pharmaceuticals raised is not a complete cap table — figures are estimates only.

How much did Gilgamesh Pharmaceuticals raise?

How much Gilgamesh Pharmaceuticals raised, when disclosed, informs the estimated Gilgamesh Pharmaceuticals valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.

How much money did Gilgamesh Pharmaceuticals raise?

How much money Gilgamesh Pharmaceuticals raised, when a public figure is available, is a model input for the estimated Gilgamesh Pharmaceuticals valuation on this profile. Estimates only — not a complete cap table.

What is Gilgamesh Pharmaceuticals series funding?

Gilgamesh Pharmaceuticals series funding, when a public raise is disclosed, informs the estimated Gilgamesh Pharmaceuticals valuation here. Not a complete financing history.

What company is Andrew Kruegel building?

Andrew Kruegel is Founder at Gilgamesh Pharmaceuticals, a Y Combinator-backed startup (batch S20).

What does Gilgamesh Pharmaceuticals do?

Gilgamesh Pharmaceuticals — Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…

What YC batch is Andrew Kruegel from?

Andrew Kruegel is associated with Y Combinator batch S20.

Where did Andrew Kruegel go to school?

Public profiles associate Andrew Kruegel with Ph.D. in Chemistry from Stanford University.

What other companies is Andrew Kruegel connected to?

Public associations for Andrew Kruegel include Harvard University, Y Combinator.

Where is Andrew Kruegel based?

Public directory data lists Andrew Kruegel's region as United States of America.

What industry is Andrew Kruegel in?

Andrew Kruegel is listed under Healthcare, Drug Discovery and Delivery.

How big is Gilgamesh Pharmaceuticals?

Public data lists Gilgamesh Pharmaceuticals's team size as 15.

What else is notable about Andrew Kruegel?

Stanford University.

Is Entrepreneurial Check affiliated with Y Combinator?

No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.